Background: Limb girdle muscular dystrophy (LGMD) is a phenotypic expression of a heterogeneous group of diseases and sarcoglycanopathy is one of the causes of LGMD. There is only one study on sarcoglycanopathies in the Indian lit-erature. No data is available from northern India. Materials and Methods: All cases of muscular dystrophies, which were diagnosed in our laboratory in the last six years, were re-viewed. Immunohistochemistry for various sarcoglycan pro-teins was done. Clinical features and pathological findings of the cases that were diagnosed as sarcoglycanopathies were reviewed. Results: In the last 6 years (1998-June 2004), we received 1435 muscle biopsies, of which 498 cases were of muscular dystrophies, and 13 cases were of ...
International audienceSarcoglycanopathies are the third most common cause of autosomal recessive lim...
Limb girdle muscular dystrophies (LGMD) are characterized by involvement of the pelvic and shoulder ...
OBJECTIVE: To determine the clinical spectrum of limb-girdle muscular dystrophy 2E (LGMD2E) and to i...
BACKGROUND: Limb girdle muscular dystrophy (LGMD) is a phenotypic expression of a heterogeneous grou...
Background: While the clinical and immunocytochemical features of sarcoglycanopathies have been repo...
Background : Limb girdle muscular dystrophy (LGMD) is a heterogeneous group of disorders characteriz...
OBJECTIVES: To characterise the pattern and spectrum of involvement on muscle MRI in a large cohor...
Full list of author information is available at the end of the articleBackground Muscular dystrophie...
INTRODUCTION: Limb-girdle muscular dystrophy presents with heterogeneous clinical and molecular feat...
Contains fulltext : 58822.pdf (publisher's version ) (Closed access)Limb-girdle mu...
Background : While the clinical and immunocytochemical features of sarcoglycanopathies have been rep...
The recent years have seen remarkable progress in the field of limb girdle muscular dystrophies (LGM...
BACKGROUND: The autosomal recessive limb-girdle muscular dystrophies (LGMDs) are a group of genetic...
Different genetic mutations underlying distinct pathogenic mechanisms have been identified as cause ...
Sarcoglycanopathies include four subtypes of autosomal recessive limb-girdle muscular dystrophies (L...
International audienceSarcoglycanopathies are the third most common cause of autosomal recessive lim...
Limb girdle muscular dystrophies (LGMD) are characterized by involvement of the pelvic and shoulder ...
OBJECTIVE: To determine the clinical spectrum of limb-girdle muscular dystrophy 2E (LGMD2E) and to i...
BACKGROUND: Limb girdle muscular dystrophy (LGMD) is a phenotypic expression of a heterogeneous grou...
Background: While the clinical and immunocytochemical features of sarcoglycanopathies have been repo...
Background : Limb girdle muscular dystrophy (LGMD) is a heterogeneous group of disorders characteriz...
OBJECTIVES: To characterise the pattern and spectrum of involvement on muscle MRI in a large cohor...
Full list of author information is available at the end of the articleBackground Muscular dystrophie...
INTRODUCTION: Limb-girdle muscular dystrophy presents with heterogeneous clinical and molecular feat...
Contains fulltext : 58822.pdf (publisher's version ) (Closed access)Limb-girdle mu...
Background : While the clinical and immunocytochemical features of sarcoglycanopathies have been rep...
The recent years have seen remarkable progress in the field of limb girdle muscular dystrophies (LGM...
BACKGROUND: The autosomal recessive limb-girdle muscular dystrophies (LGMDs) are a group of genetic...
Different genetic mutations underlying distinct pathogenic mechanisms have been identified as cause ...
Sarcoglycanopathies include four subtypes of autosomal recessive limb-girdle muscular dystrophies (L...
International audienceSarcoglycanopathies are the third most common cause of autosomal recessive lim...
Limb girdle muscular dystrophies (LGMD) are characterized by involvement of the pelvic and shoulder ...
OBJECTIVE: To determine the clinical spectrum of limb-girdle muscular dystrophy 2E (LGMD2E) and to i...